Early Stage Biotech VC, 5AM Ventures, Grabs $250 Million
Published: Dec 05, 2013
Like its name suggests, 5AM Venture Management likes to place its bets early in the life of a company. Now it has reloaded with another $250 million to put to work in more early-stage biotech companies. Menlo Park, CA-based 5AM Ventures said this week it has closed on 5AM Ventures IV, its fourth fund since it got going in 2002. The venture firm now has $685 million of total cash under management, including its most recent $200 million fund that closed almost exactly three years ago in December 2009, during some of the darker days for early-stage biotech venture capital.
Help employers find you! Check out all the jobs and post your resume.